Fiel, Merry Mae T.

HRN: 29-02-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2026
METRONIDAZOLE 500MG (TAB)
05/23/2026
05/29/2026
PO
500mg
TID
Non-institutional Delivery NSVD
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines